Jesper Bøving Email & Phone Number

Region Zealand, Denmark

CMC Development

Main responsibility: Responsible for development of all new NN compounds received from research units and until implementation in production. Main achievements: The area was created from almost scratch in 2005 – totalling today app. 1,650 employees from industrial operators to protein chemistry specialists, located at four different sites in Greater.

Diabetes Active Pharmaceutical Ingredients, Senior Vice President

Main responsibility: All bulk insulin production at NN, 10 major facilities in Kalundborg, DK and all supporting pilot plants and labs (placed in site Ba). Main achievements: Extensive optimisations to the extent that ample overcapacity was generated, introduction and implementation of a ‘lean culture’, manning reduced from 2000 to app. 1,500 though.

Diabetes Bulk Production

Main responsibility: All bulk insulin production at NN, 10 major facilities in Ka.Main achievements: Brought area in good GMP in control, expanded the area with 5 new major facilities – total investments to the tune of 1.5 B$, expanded manning from less than 400 to more than 2000 (app. 1,000 blue-collars and 1,000 white-collars of which 350 had a M.Sc or.

Diabetes Pharmaceutical Site Ba

Main responsibilities: Responsible for all fill and inspection of insulin products in DK, four major facilities on two sites.Main achievements: Reorganised the area to deal with steep rising demands re GMP, expanded from 379 to more than 850 employees in three years, closed down one major facility and increased output and productivity from the area with.

Strategic Leadership Programme

Senior Executive Programme: Challenging Leaders To Create The Future.

Global Strategic Management

Executive Leadership

Building High Performance Boards Program (Bhpb)

B.Sc.Com., Hd In Organisation And Strategy

Master Of Science (Msc), Engineering Chemistry